ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 13 filers reported holding ACASTI PHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $229,000 | – | 275,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MITCHELL MCLEOD PUGH & WILLIAMS INC | 45,000 | $9,000 | 0.01% |
| Virtu Financial LLC | 134,296 | $27,000 | 0.01% |
| Sterling Investment Advisors, Ltd. | 40,000 | $8,000 | 0.00% |
| Sargent Investment Group, LLC | 16,750 | $3,000 | 0.00% |
| OPPENHEIMER & CO INC | 194,786 | $39,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 4,500 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,235 | $12,000 | 0.00% |
| AVANTAX ADVISORY SERVICES, INC. | 16,750 | $3,000 | 0.00% |
| MORGAN STANLEY | 38,072 | $8,000 | 0.00% |